Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Yuke TIAN"'
Autor:
Xin Yang, Changchun Wu, Wenwen Liu, Kaiyu Fu, Yuke Tian, Xing Wei, Wei Zhang, Ping Sun, Huaichao Luo, Jian Huang
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 24, Iss , Pp 404-411 (2024)
Lung cancer is the main cause of cancer-related deaths worldwide. Due to lack of obvious clinical symptoms in the early stage of the lung cancer, it is hard to distinguish between malignancy and pulmonary nodules. Understanding the immune responses i
Externí odkaz:
https://doaj.org/article/e98f384dba6947bfb42f0e585b5688f4
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3496-3503 (2022)
Abstract Background This multicenter phase 1b/2 trial aimed to explore the maximum tolerated dose (MTD), activity, and safety of anlotinib plus chemotherapy in patients with T790M‐negative epidermal growth factor receptor (EGFR)‐mutant advanced n
Externí odkaz:
https://doaj.org/article/c2bed5f248224567be32a29cb894d4b0
Autor:
Yuke TIAN, Tian TIAN, Ping YU, Li REN, Youling GONG, Wenxiu YAO, Xi ZHANG, Jun YIN, Lang HE, Li CHEN, Ke WANG, Meijuan HUANG, Juan LI
Publikováno v:
Chinese Journal of Lung Cancer, Vol 23, Iss 8, Pp 655-661 (2020)
Background and objective Anaplastic lymphoma kinase (ALK) rearrangement is a common driver gene of non-small cell lung cancer (NSCLC). Ceritinib is a second-generation ALK inhibitor, which can bring survival benefits to ALK-positive metastatic NSCLC.
Externí odkaz:
https://doaj.org/article/459da133d447431ba40b1da8e0541536
Autor:
Xiaoqian Li, Xuesong Tong, Bin Liu, Zeng Li, Jing Ding, Jiang Li, Min Zheng, Yuke Tian, Siyou Yan, Meiling Huang, Jun Ge
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Objective Heat shock protein 90α (HSP90α) is associated with cancer development, progression, and metastasis. This study assessed the relationships of plasma HSP90α levels with treatment efficacy and prognosis in lung cancer. Methods In this retro
Externí odkaz:
https://doaj.org/article/ae271adffbe9480b9e45ccc7e1752b4c
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objectives This study aimed to explore the expression profile of the Forkhead box protein L2 gene ( FOXL2 ) and to determine its prognostic value and associated epigenetic and genetic alterations in patients with laryngeal squamous cell carcinoma (LS
Externí odkaz:
https://doaj.org/article/b7b405bd05594ba69215973db07e31b9
Publikováno v:
Pain Research and Management, Vol 2017 (2017)
Background. This study aimed to investigate the use of human bone marrow mesenchymal stem cells (hBMSCs) genetically engineered with the human proenkephalin (hPPE) gene to treat bone cancer pain (BCP) in a rat model. Methods. Primary cultured hBMSCs
Externí odkaz:
https://doaj.org/article/0fa690d89a8c4fe6b0d4c3f96b4c424e
Autor:
Ke Zhu, Yuke Tian, Xiaomei Dong, Babatunde O. Akinwunmi, Casper J. P. Zhang, Jian Huang, Wai-kit Ming
Publikováno v:
Archives of Gynecology and Obstetrics. 306:173-187
The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020.Si
Publikováno v:
The Oncologist
Crizotinib, a multitargeted MET/ALK/ROS1 tyrosine kinase inhibitor, has been approved for the treatment of ROS1 fusion–positive non‐small cell lung cancers (NSCLCs). However, “on‐target” or “off‐target” resistance alterations often em
Publikováno v:
Annals of Palliative Medicine. 10:10095-10101
ALK-positive histiocytosis is a rare malignancy which was first described in 2008 and recognized as a systemic histiocytic disorder that can affect multiple organs. Less than 20 cases were reported to date, and much fewer cases were presented as diss
Publikováno v:
Journal of Clinical Anesthesia. 59:106-111
The study was to determine the analgesic effect of ultrasound-guided intercostal nerve block (ICNB) and single-injection erector spinae plane block (ESPB) in comparison with multiple-injection paravertebral block (PVB) after thoracoscopic surgery.Ran